Galcanezumab cut in half the number of days that most patients suffered from a migraine in a month, and did so without significant side effects, researchers reported.
from WebMD Health https://ift.tt/2Jd52rJ
Galcanezumab cut in half the number of days that most patients suffered from a migraine in a month, and did so without significant side effects, researchers reported.
No comments:
Post a Comment